| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Abbvie Inc. (ABBV) has 5 insiders with recent SEC Form 4 filings, including 2 buys and 13 sells. ABBV is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 177.3K | $38.38M | - | |
| VP | 68.3K | $14.79M | - | |
| Dir | 28.5K | $6.17M | - | |
| Dir | 10.3K | $2.22M | - | |
| Dir | 707 | $153.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 29, 2018 | Gosebruch Henry O53 | EVP, Chief Strategy Officer | Sell | 42,450 | $90.10 | $3,824,940.27 | -58.3% | |
| Aug 17, 2018 | Severino Michael70 | EVP, R&D And CSO | Sell | 50,000 | $97.52 | $4,876,060.28 | -20.5% | |
| Jun 27, 2018 | Tilton Glenn F | Director | Buy | 5,400 | $91.90 | $496,274.04 | +15.7% | |
| Jun 20, 2018 | Rapp Edward J | Director | Buy | 1,013 | $98.63 | $99,908.75 | +5.1% | |
| Jun 15, 2018 | Richmond Timothy J.47 | SVP, Human Resources | Sell | 17,588 | $99.47 | $1,749,485.40 | -100% | |
| Mar 1, 2018 | Schumacher Laura J | Executive Vice President | Sell | 25,000 | $117.85 | $2,946,147.50 | -20.3% | |
| Mar 1, 2018 | Alban Carlos | EVP, Commercial Operations | Sale+OE | 83,574 | $114.49 | $9,568,736.62 | -14.3% | |
| Mar 1, 2018 | Chase William J | EVP, Chief Financial Officer | Sale+OE | 70,928 | $117.18 | $8,311,640.44 | -17.7% | |
| Feb 28, 2018 | Saleki-Gerhardt Azita | SVP, Operations | Sell | 1,337 | $117.77 | $157,457.82 | -1.4% | |
| Feb 28, 2018 | Severino Michael70 | EVP, R&D And CSO | Sell | 2,643 | $117.93 | $311,683.70 | -2.0% |